This study is a first in human, two-stage single arm non-comparative study of safety and performance. The aim of the study is to asses the safety and the clinical performance of a new device : the MATTISSE tissu engineering chamber.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Safety objective: To assess the 6 months surgical complications rate of MATTISSEĀ® TEC implant-based immediate breast reconstruction. Adverse events will be recorded.
Timeframe: 6 months post-surgery
Performance objective: To assess the efficacy at 6 months post-operation of breast reconstruction using MATTISSEĀ® breast implants in patients undergoing breast reconstitution after total mastectomy surgery for cancer.
Timeframe: 6 months post-surgery